Cargando…

Mesothelioma Driver Genes, Ferroptosis, and Therapy

Detalles Bibliográficos
Autores principales:	Felley-Bosco, Emanuela, Gray, Steven G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890845/ https://www.ncbi.nlm.nih.gov/pubmed/31828040 http://dx.doi.org/10.3389/fonc.2019.01318

Ejemplares similares

Hedgehog Signaling in Mesothelioma: 2019 Status
por: Felley-Bosco, Emanuela
Publicado: (2019)

Live-Cell Mesothelioma Biobank to Explore Mechanisms of Tumor Progression
por: Oehl, Kathrin, et al.
Publicado: (2018)

Special Issue on Mechanisms of Mesothelioma Heterogeneity: Highlights and Open Questions
por: Felley-Bosco, Emanuela
Publicado: (2018)

Exploring the Expression of the «Dark Matter» of the Genome in Mesothelioma for Potentially Predictive Biomarkers for Prognosis and Immunotherapy
por: Felley-Bosco, Emanuela
Publicado: (2023)

Hedgehog Signaling in Malignant Pleural Mesothelioma
por: Felley-Bosco, Emanuela, et al.
Publicado: (2015)

Non-Coding Transcript Heterogeneity in Mesothelioma: Insights from Asbestos-Exposed Mice
por: Felley-Bosco, Emanuela, et al.
Publicado: (2018)

RNA editing in mesothelioma: a look forward
por: Hariharan, Ananya, et al.
Publicado: (2020)

Editorial: Understanding the Interplay Between the Tumor Immune Microenvironment and Genetic Alterations in Thoracic Malignancies
por: Pasello, Giulia, et al.
Publicado: (2022)

Genomic landscape of pleural and peritoneal mesothelioma tumours
por: Hiltbrunner, Stefanie, et al.
Publicado: (2022)

The Pattern of RNA Editing Changes in Pleural Mesothelioma upon Epithelial-Mesenchymal Transition
por: Felley-Bosco, Emanuela, et al.
Publicado: (2023)

Prognostic Value of EMT Gene Signature in Malignant Mesothelioma
por: Wu, Licun, et al.
Publicado: (2023)

Stem Cell Factor-Based Identification and Functional Properties of In Vitro-Selected Subpopulations of Malignant Mesothelioma Cells
por: Blum, Walter, et al.
Publicado: (2017)

Posttranscriptional Regulation Controls Calretinin Expression in Malignant Pleural Mesothelioma
por: Kresoja-Rakic, Jelena, et al.
Publicado: (2017)

Oncolytic Viral Therapy for Mesothelioma
por: Pease, Daniel F., et al.
Publicado: (2017)

GAS5 long non-coding RNA in malignant pleural mesothelioma
por: Renganathan, Arun, et al.
Publicado: (2014)

Lipid metabolism in ferroptosis and ferroptosis-based cancer therapy
por: Sun, Yonghao, et al.
Publicado: (2022)

Autophagy Correlates with the Therapeutic Responsiveness of Malignant Pleural Mesothelioma in 3D Models
por: Barbone, Dario, et al.
Publicado: (2015)

Establishment of immortalized murine mesothelial cells and a novel mesothelioma cell line
por: Blum, Walter, et al.
Publicado: (2015)

Editorial: Emerging Therapies for Malignant Mesothelioma
por: van Zandwijk, Nico, et al.
Publicado: (2020)

The “don't eat me” signal CD47 is a novel diagnostic biomarker and potential therapeutic target for diffuse malignant mesothelioma
por: Schürch, Christian M., et al.
Publicado: (2017)

Human agonistic TRAIL receptor antibodies Mapatumumab and Lexatumumab induce apoptosis in malignant mesothelioma and act synergistically with cisplatin
por: Belyanskaya, Larisa L, et al.
Publicado: (2007)

New Perspectives on Diagnosis and Therapy of Malignant Pleural Mesothelioma
por: Rossini, Marika, et al.
Publicado: (2018)

Expression of the Stem Cell Factor Nestin in Malignant Pleural Mesothelioma Is Associated with Poor Prognosis
por: Thies, Svenja, et al.
Publicado: (2015)

Epigenetic Regulation of Ferroptosis-Associated Genes and Its Implication in Cancer Therapy
por: Pei, Yanzi, et al.
Publicado: (2022)

Genomic and Transcriptomic Analyses of Malignant Pleural Mesothelioma (MPM) Samples Reveal Crucial Insights for Preclinical Testing
por: Laure, Alexander, et al.
Publicado: (2023)

Viral Mimicry Response Is Associated With Clinical Outcome in Pleural Mesothelioma
por: Sun, Suna, et al.
Publicado: (2022)

Identification of a seven glycopeptide signature for malignant pleural mesothelioma in human serum by selected reaction monitoring
por: Cerciello, Ferdinando, et al.
Publicado: (2013)

Novel Insights Into Mesothelioma Therapy: Emerging Avenues and Future Prospects
por: Kuryk, Lukasz, et al.
Publicado: (2022)

Ferroptosis: A New Strategy for Cancer Therapy
por: Chen, Yu, et al.
Publicado: (2022)

A Novel Ferroptosis-Related 4-Gene Prognostic Signature for Cholangiocarcinoma and Photodynamic Therapy
por: Zhang, Zi-jian, et al.
Publicado: (2021)

A Case Report of Mesothelioma Response to Endocrine Therapy in Synchronous Breast Cancer and Pleural Epithelioid Mesothelioma: A Double Exemestane Effect
por: Pina, Marta, et al.
Publicado: (2022)

Identification of cis- and trans-acting elements regulating calretinin expression in mesothelioma cells
por: Kresoja-Rakic, Jelena, et al.
Publicado: (2016)

Antiangiogeneic Strategies in Mesothelioma
por: Nowak, Anna K., et al.
Publicado: (2020)

Malignant Pleural Mesothelioma: State-of-the-Art on Current Therapies and Promises for the Future
por: Nicolini, Fabio, et al.
Publicado: (2020)

Surgery for Mesothelioma After Radiation Therapy (SMART); A Single Institution Experience
por: Breen, William G., et al.
Publicado: (2020)

Insights Into Ferroptosis, a Novel Target for the Therapy of Cancer
por: Wang, Hong-Tao, et al.
Publicado: (2022)

Editorial: Emerging strategies for cancer therapy targeting ferroptosis
por: Li, Manshan, et al.
Publicado: (2023)

Defining and targeting tumor-associated macrophages in malignant mesothelioma
por: Wu, Licun, et al.
Publicado: (2023)

Editorial: Thy1/CD90 Surface Glycoprotein: Sensor of Microenvironment?
por: Felley-Bosco, Emanuela, et al.
Publicado: (2019)

Inhibition of autophagy sensitizes malignant pleural mesothelioma cells to dual PI3K/mTOR inhibitors
por: Echeverry, N, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_u5mejjg472vpjiqqpdc818ecnf